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INTRODUCTION
Asthma is a complex respiratory condition that involves interplay between genetic predisposition,
environmental, and immunological factors (Edwards et al., 2012). It is considered to be one of the
most common chronic diseases, affecting ∼300 million people (Masoli et al., 2004), and causing
an estimated 250,000 deaths annually (Bateman et al., 2008). Furthermore, because of an increased
Westernized lifestyle and urbanization in developing countries, it is estimated that by 2025 the
global burden of asthma will increase by 100 million people (Masoli et al., 2004).
An increase in the occurrence of allergic diseases, including asthma, was initially attributed to
the “hygiene hypothesis,” suggesting that a reduced exposure to microbes during the first years
of life plays a role in the development of allergic diseases (Strachan, 1989, 2000). Although this
hypothesis is widely accepted, studies showed that reducedmicrobial exposure cannot fully account
for the increased prevalence of asthma, rhinitis, or neurodermitis (Mallol, 2008; Brooks et al.,
2013; Kramer et al., 2013). Alternative hypotheses or reformulations of the “hygiene hypothesis”
(Hunter, 2012), such as the “microbiota hypothesis” (Wold, 1998), the “old friends hypothesis”
(Rook, 2012), the “microbial deprivation hypothesis” (Bloomfield et al., 2006), the “biodiversity
hypothesis” (Hanski et al., 2012) and the “disappearing microbiota hypothesis” (Blaser and Falkow,
2009; Taube and Müller, 2012) soon followed; all of which mainly postulate that dysbiosis of the
human gastro-intestinal tract (GIT) microbiome may contribute to intra- and extra-intestinal
immune-mediated diseases (Penders et al., 2007; Štšepetova et al., 2007; Sekirov et al., 2010;
Clemente et al., 2012; Russell and Finlay, 2012). Understanding which bacteria from our GITs
contribute to the development or prevention of allergic asthma may result in further research
to discern the mechanisms behind bacterial-host interactions and potentially facilitate treatment
strategies.
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METHODS USED TO STUDY THE ROLE OF
HUMAN FECAL BACTERIA IN ASTHMA
Although culture-independent techniques have revolutionized
the world of microbiology (Suau et al., 1999; Zoetendal et al.,
2006; Rajilic´-Stojanovic´ et al., 2007); conventional culture-
dependent techniques have been the method widely used to
study the role of human fecal bacteria in asthma (Mansson and
Colldahl, 1965; Stockert, 2001; Nambu et al., 2008; Vael et al.,
2008; Bisgaard et al., 2011). To date, the culture-independent
techniques used to characterize fecal bacteria from patients with
asthma include quantitative real-time polymerase chain reaction
(qPCR) (Van Nimwegen et al., 2011), denaturing gradient gel
electrophoresis (DGGE) (Bisgaard et al., 2011; Vael et al., 2011),
fluorescent in situ hybridization (FISH) (Salminen et al., 2004),
and massively parallel high-throughput sequencing of the 16S
ribosomal RNA (rRNA) gene (Arrieta et al., 2015). Despite
the advantage of detecting uncultivable bacteria, these culture-
independent techniques are not without limitations. Among
others, they do not allow for whole community analysis of the
microbial population (Sekirov et al., 2010; Fraher et al., 2012;
Sankar et al., 2015), which is considered key in determining
the patterns of fecal bacteria associated with health and disease
states (Schippa and Conte, 2014). For example, qPCR and FISH
do not provide identification of novel organisms as they are
used to characterize and quantify targeted groups of bacteria
(Sekirov et al., 2010; Fraher et al., 2012). DGGE, a band-based
method for determining bacterial diversity, does not enable direct
identification of bacteria (Sekirov et al., 2010; Fraher et al.,
2012). Furthermore, DGGE has low bacterial detection limits and
limited phylogenetic resolution (Sekirov et al., 2010). Although
massively parallel high-throughput sequencing of the 16S rRNA
gene provides an almost comprehensive view of bacterial
communities; it does not provide classification at species-level
(Gosalbes et al., 2012; Arrieta et al., 2015). The importance
of species-level characterization in health and disease states
has been demonstrated in murine models of allergic diseases
(Karimi et al., 2009; Russell et al., 2012; Kim et al., 2013). An
overgrowth of the genus Lactobacillus has been associated with
an increased risk of allergic asthma (Russell et al., 2012), while
the species L. reuteri and L. rhamnosus provide a protective role
in allergic airway disease (Karimi et al., 2009; Kim et al., 2013).
In comparison to 16S rRNA gene sequencing techniques; whole
genome shotgun (WGS) sequencing offers a higher and more
reliable resolution of microbiota profiles at lower taxonomic
levels (Morgan and Huttenhower, 2014; Van Dijk et al., 2014;
Ranjan et al., 2015). For example, WGS sequencing is able to
improve the issue related to the Bifidobacterium amplification
bias by certain primer sets (Kurokawa et al., 2007; Sim et al., 2012;
Walker et al., 2015). In addition, it allows for determination of
the metabolic and functional properties of fecal bacteria which
may greatly contribute to our understanding of the role of
fecal bacteria in health and disease (Qin et al., 2012; Arrieta
et al., 2015; Quince et al., 2015). However, despite the number
of advantages that WGS sequencing provides, it has not been
incorporated by any of the studies investigating the importance
of fecal bacteria in the development of asthma. Furthermore, a
causal link between fecal bacterial profiles and asthma in humans
has recently been confirmed using murine models (Arrieta et al.,
2015). To the best of our knowledge, this is the only report of
its kind where the causal role of the fecal bacteria (Lachnospira,
Veillonella, Faecalibacterium, and Rothia), which potentially
confers protection against the development of asthma in humans,
was demonstrated using germ-free mice models (Arrieta et al.,
2015).
WHAT DO STUDIES IN HUMANS REVEAL
ABOUT THE ROLE OF FECAL BACTERIA
IN ASTHMA?
Although prospective longitudinal studies are key in
demonstrating the role of fecal bacteria in disease development
(Zhao, 2013); we identified only two studies which assessed
whether fecal bacterial profiles sampled over time preceded
the occurrence of asthma at later stages in life (Bisgaard et al.,
2011; Arrieta et al., 2015). Bisgaard et al. (2011) did not report
a significant association (Bisgaard et al., 2011). In contrast,
Arrieta et al. (2015) found significantly reduced abundances
of the bacterial genera Lachnospira, Veillonella, Rothia, and
Faecalibacterium in infants at risk for asthma, as evidenced
using the Asthma Predictive Index (API) (Arrieta et al., 2015).
Moreover, in a prospective birth cohort study conducted in
Belgium (using fecal specimens sampled at 3 weeks of age);
the detection of Bacteroides (B. fragilis, B. finegoldii, and B.
thetaiotaomicron), Ruminococcus (R. productus and R. hansenii),
and Clostridium spp. was associated with an increased risk for
asthma development (as based on the API) (Vael et al., 2011).
At species-level, the prospective birth cohort study by Van
Nimwegen et al. (2011) conducted in the Netherlands reported
a two-fold increased risk of asthma at 6–7 years in infants
colonized with Clostridium difficile at 1 month of life (OR= 2.06;
95% CI 1.16–3.64) (Van Nimwegen et al., 2011).
All prospective birth cohort studies, except for the study
by Nambu et al. (2008), made use of the API when assessing
asthma as an outcome at <5 years of age (Vael et al., 2008,
2011; Arrieta et al., 2015). The API, incorporated by three
studies cited in this review, is an example of a predictive
assessment for asthma development later in life, recommended
for young children experiencing recurrent wheeze (Castro-
Rodriguez, 2010). Considering that asthma diagnosis in children
<5 years of age is challenging and often based on symptom
patterns, clinical assessment of the family history and the
presence of atopy (Pedersen, 2007; Sly et al., 2008; Pedersen
et al., 2011); the use of predictive assessments, such as the API, is
essential. However, despite its success in developed countries, the
API should be used with caution in infants from low and middle
income countries (LMICs) (Zar and Levin, 2012). This may be
explained by the fact that young children from LMICs are more
commonly affected by viral lower respiratory tract infections
(LRTIs) or pulmonary tuberculosis. Furthermore, it has been
suggested that atopy may be less strongly associated with asthma
in these settings compared to the more developed countries (Zar
and Levin, 2012). This suggests that non-atopic wheeze may be
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the primary form of asthma in these children, making the API,
which relies primarily on the presence of atopy for assessing the
risk of asthma, a less reliable predictive assessment tool in LMICs
(Zar and Levin, 2012).
FACTORS INFLUENCING FECAL
BACTERIAL PROFILES AND POTENTIALLY
ASTHMA
Both murine models and human studies have provided evidence
that early life changes in the GITmicrobiome are most influential
in the development of allergic asthma (Russell et al., 2013; Arrieta
et al., 2015). Some of the well described factors responsible for
these early life changes in fecal bacterial profiles, which have also
been associated with childhood asthma, are mode of delivery,
feeding practices, and antibiotic use (Kozyrskyj et al., 2011).
Mode of Delivery
A number of childhood studies have reported that infants
delivered via cesarean section are at an increased risk for the
development of asthma (Thavagnanam et al., 2008). However,
these studies do not account for confounding factors that may
be associated independently with asthma, as well as changes in
fecal bacterial profiles, which will allow for determining the true
effect of external factors on fecal microbiota and the resultant
health outcome. To date, only a single study using mediation
analysis (Van Nimwegen et al., 2011) supported the role of
mode and place of delivery (independent variable) in C. difficile
colonization (mediator variable), together with its consequent
impact on asthma development via modulation of C. difficile
profiles (dependent variable).
Feeding Practices
Although, it has been reported that breastfeeding has the
potential to protect against allergic airway disease (Dogaru et al.,
2014), no studies have used mediation analysis (as performed by
Van Nimwegen et al. (2011)) to determine whether bacteria from
breast milk protect against asthma via the modulation of infant
fecal bacteria.
Antibiotic Use
In humans, a modest increased risk of asthma development,
associated with antibiotic use, has been reported (Marra et al.,
2009; Risnes et al., 2010; Murk et al., 2011; Penders et al., 2011).
To date, only fecal C. difficile colonization has been associated
with the occurrence of asthma (Van Nimwegen et al., 2011),
which might be explained (among other factors) by a loss of
intestinal commensal microbes through the use of antibiotics
(Azad and Kozyrskyj, 2012).
POTENTIAL MECHANISMS SUPPORTING
THE ROLE OF GASTROINTESTINAL
BACTERIA IN ASTHMA
The exact mechanisms by which GIT bacteria may influence the
development of respiratory diseases are unclear; however recent
work has demonstrated that crosstalk between host mucosal
immune cells and resident microbes significantly influences the
risk for respiratory disease (Forsythe, 2011; Samuelson et al.,
2015; Vital et al., 2015). A central player in this regulation
of pulmonary immunity by the GIT microbiome are dendritic
cells (DCs) (McLoughlin and Mills, 2011) (Figure 1). Intestinal
DCs encounter bacterial antigens presented in organized GIT
immune tissue (i.e., lamina propria and Peyer’s patches) and
also directly sample lumen residing bacteria in the GIT by
extending their dendrites into the intestinal lumen (Salzman,
2011). This sampling of intestinal bacterial antigens results in
DCs co-ordinating B and T cell subset expansion both locally
(Peyer’s patches and lamina propria) as well as systemically
(e.g mesenteric lymph nodes) (Hill and Artis, 2010) (Figure 1).
This results in DC-guided local and systemic immune education
driven by microbiota associated antigens which has profound
effects not just in the intestine but throughout the body (Hill and
Artis, 2010; Russell and Finlay, 2012) (Figure 1). An important
consequence of this effect of GIT bacteria is manifested in
subsequent host T-cell immune responses in the lungs and
has been particularly well demonstrated in murine models of
asthma (Herbst et al., 2011; Navarro et al., 2011; Konieczna
et al., 2012; Oertli et al., 2012). For example, B. fragilis and
Clostridium species (cluster IV and XIVa), both intestinally
restricted bacteria, can drive induction of T regulatory (Treg)
cells and associated elevated secretion of the regulatory cytokine
IL-10 in mesenteric lymph nodes to mediate protection against
allergic T-helper cell (Th-) 2 airway inflammation (Round
et al., 2011) (Figure 1). Other studies have demonstrated that
early life depletion of Bacteroidetes species using vancomycin
abrogates the ability of mice to launch Treg protection from
allergic asthma (Atarashi et al., 2011; Russell et al., 2012).
In addition, raised levels of Helicobacter pylori has also been
shown to elicit protection against the development of asthma,
again, via the induction of Treg cells (Arnold et al., 2011).
Interestingly this effect may, in part at least, also be due to de
novo production of IL-10 orthologs by H. pylori driving this
Treg induction. Moreover, oral administration of probiotics (L.
reuteri, L. rhamnosus GG, Bifidobacterium breve, or B. lactis)
can impair the onset of ovalbumin induced allergic airway
inflammation; again related to the reduced induction of Treg
cells (Feleszko et al., 2007; Karimi et al., 2009). Taken together,
these and other studies are generating an important profile
of the microbial species driving Treg dependent protection
against allergic airway inflammation. Other studies have also
identified bacteria which may drive the onset of allergic
pathology. Segmented filamentous bacteria (SFB), non-cultivable
Clostridia-related host-specific species (Gaboriau-Routhiau et al.,
2009), and members of the cytophaga-flavobacter-bacteroides
(CFB) phylum, for example, have been shown to promote
differentiation of pro-inflammatory Th17 cells associated with
airway inflammation (Ivanov et al., 2008; Atarashi et al., 2011)
(Figure 1).
Although the studies described here provide insight into the
potential role of GIT bacteria in the development of asthma in
murine models; more studies are needed to explore the manner
in which whole GIT bacterial communities, from asthmatic
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FIGURE 1 | Schematic representation of the potential immunological interaction between the gastrointestinal tract microbiota and the development of
asthma. 1. Dendritic cells (DCs) sample antigen in the lamina propria (LP) and Peyer’s patches (PP) of the small intestine; and by extending their dendrites into the
intestinal lumen. 2. The interactions between DCs and microbial associated molecular patterns (MAMPs) allow DCs to present antigen to naïve lymphocytes in the
mesenteric lymph nodes (mLNs). For example, DCs present epitopes together with major histocompatibility complex (MHC) class II and specific immunomodulatory
cytokines to naïve CD4+ T cells. This elicits proliferation and activation of various T cell subsets which 3. enter systemic circulation via the efferent lymph, homing to
mucosal surfaces inside and outside of the gastrointestinal tract (GIT). 4. TGF-β contributes to the differentiation of Th17 cells, which produce cytokines (such as
IL-17) involved in pro-inflammatory responses. 5. IL-12 associated cytokines are responsible for Th1 cell differentiation. This regulates the induction of IL-10, which
supresses pro-inflammatory responses. 6. Presentation of vitamin B2, from a wide range of bacteria and fungi via MR1 molecules, to mucosa-associated invariant T
(MAIT) cells results in a rapid production of pro-inflammatory Th1/Th17 cytokines. MAIT cells’ preferential location in the GIT LP and PP, as well as their
pro-inflammatory responses in reaction to bacterial metabolites such as vitamin B2, may support their potential role in asthma pathogenesis via the “gut-lung axis” in a
similar manner to what has been proposed for DCs. 7. Circulating short-chain fatty acids (SCFAs) contribute to the protection against allergic airway inflammation via
enhanced generation of DC precursors in bone marrow, followed by seeding of the lungs with DCs with high phagocytic capacity and limited ability to promote Th2
cell effector function. 8. Localization of inflammatory GIT bacteria in the GIT mucus layer may induce strong IgA responses and chronic local inflammation. An influx of
inflammatory Th17, Th1, and neutrophil cells in the GIT could potentially circulate to the lungs where they may contribute to asthma pathogenesis. This hypothesis
may be supported by the strong associations found between irritable bowel disease (IBD) and asthma.
and non-asthmatic participants, interact with the innate and
adaptive immune cells of the GIT, as well as their subsequent
immune effects in the lungs. Besides, studies should also
investigate a broader scope of mechanisms to explain the role of
GIT bacteria in asthma pathogenesis. For example, a potential
mechanism in need of further investigation is the tenable role
of IgA-coated inflammatory GIT bacteria in the development
of asthmatic responses in the lungs (Figure 1). To date, no
clear link between host GIT microbiota-idiopathic intestinal
inflammation and allergic lung disease has been demonstrated.
However, our recent understanding of the involvement of IgA-
coated bacteria in intestinal inflammation (Van der Waaij et al.,
2004; Palm et al., 2014), as well as the number of clinical
studies denoting an association between inflammatory lung
disease and intestinal inflammation (Tulic et al., 2016); provides
rationale for investigating the systemic immune effect of IgA-
coated GIT bacteria. For example, it is suspected that around
50% of patients suffering from ulcerative colitis and Crohn’s
disease have subclinical pulmonary abnormalities with low-grade
airway inflammation (Kuzela et al., 1999; Mohamed-Hussein
et al., 2007). Moreover, a large cohort study, investigating 5260
IBD patients together with 21,040 non-IBD participants, recently
provided strong evidence for the association between IBD and
an increased risk for asthma (Peng et al., 2015). In support of
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this, Palm et al. (2014) clearly showed microbial localization of
IgA positive bacteria from IBD patients in the normally sterile
GIT mucosa of germ-free mice, which was not observed for
IgA negative bacteria from IBD patients (Palm et al., 2014). We
therefore hypothesize that GIT bacteria characterized by high
levels of IgA coating may enter the GIT mucosa (Palm et al.,
2014) where they may elicit systemic inflammatory responses at
extra-intestinal mucosal sites such as the lungs.
In addition to assessing the immuno-regulatory effect of the
composition of GIT bacteria in asthmatic and non-asthmatic
participants; studies should also investigate the functional
characteristics of GIT bacteria in the occurrence of asthma.
In support of this, Trompette et al. (2014) reported the role
of circulating short-chain fatty acids (SCFAs) in the protection
against allergic airway inflammation (Trompette et al., 2014)
(Figure 1). Here, microbiome metabolism in a high fiber diet
setting resulted in enhanced SCFA metabolism leading to the
generation of myeloid bone marrow precursors that gave rise
to populations of pulmonary DCs that protected against Th2
driven allergic airway disease (Trompette et al., 2014). In support
of this, Zaiss et al. (2015) demonstrated attenuated allergic
airway inflammation via a GPR41 (SCFA receptor) dependent
manner, as well as the effect of changes in GIT bacteria on SCFA
production (Zaiss et al., 2015). Furthermore, microbial vitamin
B2 (riboflavin) metabolites have been shown to activate a subset
of innate-like T cells, the mucosa-associated invariant T (MAIT)
cells, which are highly abundant in peripheral blood, mucosal
tissues, as well as the liver (Treiner et al., 2003; Le Bourhis et al.,
2013). Vitamin B2 from a wide range of bacteria and fungi are
presented to MAIT cells by MR1 molecules (Kjer-Nielsen et al.,
2012; Patel et al., 2013), followed by the rapid production of pro-
inflammatory Th1/Th17 cytokines such as interferon-gamma
(IFNγ) and IL-17 (Le Bourhis et al., 2011) (Figure 1). MAIT cells’
pro-inflammatory responses in reaction to bacterial metabolites,
together with their preferential location in the GIT lamina
propria and mesenteric lymph nodes (Treiner et al., 2003), may
support the “gut-lung axis” theory in a similar manner to what
has been proposed for DCs. Therefore, functional properties of
GIT bacteria such as dietary fiber metabolism and the production
of vitamin B2 may be an important aspect of host microbe
crosstalk.
THE POTENTIAL OF MODULATING
GASTROINTESTINAL MICROBIOTA TO
PROTECT AGAINST ASTHMA
The mechanistic insights into how GIT bacteria may protect
or contribute to the development of asthma have provided
great potential for the development of intervention studies. For
example, the administration of probiotics (beneficial live bacterial
species) (De Kivit et al., 2014), prebiotics (non-digestible food
ingredients) (Jeurink et al., 2013) or symbiotics (synergistic
nutritional supplements combining probiotics and prebiotics)
(Van de Pol et al., 2011; Van der Aa et al., 2011) have
demonstrated immune-modulatory potential via the restoration
of an altered intestinal microbiota. The efficacy of probiotic
administration (mainly Lactobacillus or Bifidobacterium spp.) in
treatment or prevention of asthma has clearly been demonstrated
in animal models (Feleszko et al., 2007; Karimi et al., 2009;
MacSharry et al., 2012; Kim et al., 2013); however data in
humans are not conclusive (Vliagoftis et al., 2008; Elazab
et al., 2013). Nevertheless, probiotic administration needs to
be carefully considered as we do not fully understand its
effect on GIT bacteria. It may also hold more complex effects
for the host (Shenderov, 2013), such as infections (Fijan,
2014) and allergic sensitization (Viljanen et al., 2005; Taylor
et al., 2007). Various factors therefore need to be taken into
account in the development of probiotics. These include the
immunological pathways behind immune responses elicited by
live bacteria and bacterial molecules (Caselli et al., 2011); the
ongoing research around what a “healthy” GIT profile should
look like (Koren et al., 2013; Knights et al., 2014) (prior to
considering modulation thereof); what the effect of probiotics
are on these “healthy” GIT profiles (Eloe-fadrosh et al., 2015);
the inter-individual variability of the human GIT microbiome
(De Filippo et al., 2010; Grzes´kowiak et al., 2012; Yatsunenko
et al., 2012; Lin et al., 2013; Ou et al., 2013; Suzuki and
Worobey, 2014); the effect of probiotics on host metabolic and
signaling pathways (Shenderov, 2013); and whether diversity
within specific bacterial taxa is of importance in immunological
tolerance (West, 2014). In addition, studies are needed to assess
the period, dose and duration of probiotic supplementation. As
for probiotics, prebiotic supplementation was not significantly
associated with the prevention of asthma in humans (Arslanoglu
et al., 2012; Osborn and Sinn, 2013); however, administration
of oligosaccharides in mice has been associated with decreased
parameters of allergic asthma (Vos et al., 2007).
It is important to also highlight the potential role of vitamin D
in modulation of the GIT bacterial community and consequent
immune responses such as asthma (Arshi et al., 2014). Vitamin
D not only acts on a number of immune cells and processes
involved in immune regulation of asthma (Brehm et al., 2009,
2010; Mann et al., 2014), but also has the potential to modulate
GIT bacterial profiles and their functions (Mai et al., 2009; Jin
et al., 2015). Thus, further exploring the therapeutic potential
of vitamin D supplementation, together with pro-, pre- and
synbiotic interventions, in modulating the host’s GIT microbiota
and its subsequent effect on allergic airway diseases such as
asthma has merit.
Moreover, understanding the effects of other GIT microbiota,
such as fungi and helminths, on the composition of GIT bacteria
is also likely to be extremely informative. For example, an
overgrowth of commensal fungal Candida species in the GIT,
as a result of antibiotic treatment, has been shown to promote
M2 macrophage activation in the lungs, as well as increased
allergic airway inflammation (Kim et al., 2014). In addition,
changes in the GIT bacterial composition of mice following
chronic infection with the murine helminth Heligmosomoides
polygyrus bakeri have been elegantly shown to protect against
house dust mite induced airway inflammation (Zaiss et al., 2015).
Importantly this study shows that these changes resulted in
elevated SCFA production that actually underlies the protective
phenotype (Zaiss et al., 2015). This and work discussed
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above from the Marsland laboratory provide strong evidence
for dietary modulation of the microbiome protecting against
allergy.
CONCLUSION AND PERSPECTIVES
A systematic search of the literature revealed that studies
investigating fecal bacteria from humans and their relationship
with asthma have been increasingly published since the
beginning of the 21st century. However, reports on the role
of fecal bacteria in the development of asthma in humans
are limited, and primarily investigate the role of select GIT
bacteria in asthma pathogenesis. Large longitudinal prospective
cohort studies, with clear definitions of asthmatic outcomes,
incorporating high-resolution methods (such as massively
parallel 16S rRNA gene sequencing, whole-genome shotgun
sequencing or culturomics), are therefore needed to determine
the role of fecal bacteria in the development of asthma in both
developed and developing countries. Studies also need to assess
the impact of covariates (such as mode of delivery and intestinal
microbes other than bacteria) on both fecal bacterial profiles
and the outcome of interest using rigorous statistical analyses.
Furthermore, studies should aim to test the causal link between
human fecal bacteria and asthma development using murine
models. Finally, the role of GIT bacteria in asthma should be
investigated alongside the airway microbiome in order not to
mask the importance of the local respiratory microbial-host
interactions. In addition, it would be interesting to assess whether
GIT bacteria impacts on corticosteroid responsiveness in asthma
(Goleva et al., 2013), as well as asthma severity and phenotypes
(Zhang et al., 2016).
Literature Search Strategy and Selection
Criteria
We systematically searched peer-reviewed articles published on
bacteria detected from feces and their association with asthma
from six electronic databases (Medline via Pubmed, Scopus via
SciVerse, Academic Search Premier, Africa-Wide Information
and CINAHL via EBSCOHost and Web of Science via Web
of Knowledge), using a combination of keywords [(microbiota∗
OR metagenome OR microbiome∗ OR “human microbiota∗”
OR “human microbiome∗” OR “gut microbiota∗” OR “gut
microbiome∗” OR “intestinal flora” OR “digestive flora” OR “gut
flora” OR feces OR stool OR faeces OR fecal OR faecal) AND
(asthma OR “bronchial asthma” OR “bronchial disease∗” OR
“respiratory sound∗” OR “lung sound∗” OR wheez∗)]. The last
literature search was 19 November 2015. All articles published
in English and French were assessed for inclusion in the
review. Original research articles investigating bacteria from fecal
specimens and their relation to asthma in humans unexposed
to antibiotic, pre- or probiotic treatments were included. In
addition, we cross-checked the reference lists of all eligible studies
included in this review for any additional articles.
AUTHOR CONTRIBUTIONS
MK, SC, and MN initiated the project. SC extracted the data
and reviewed the articles with MK. SC, CW, SM, LT, and MK
performed the statistical analysis and interpreted the results. SC,
LT, WH, HZ, MN, and MK wrote the manuscript.
FUNDING
This work was supported by the Bill and Melinda Gates
Foundation Global Health Grant (OPP1017641), the National
Research Foundation (South Africa), the Carnegie Corporation
of New York (United States of America), the US National
Institutes of Health (1U01AI110466-01A1), and the Wellcome
Trust, United Kingdom (102429/Z/13/Z). The first (SC) and the
corresponding author (MK) had full access to the study data. All
authors had final responsibility for the decision to submit the
article for publication.
ACKNOWLEDGMENTS
SC is supported by the National Research Foundation and
the Drakenstein Child Health Study, University of Cape Town
(South Africa), a birth cohort study funded by Bill and
Melinda Gates Foundation (OPP1017641). MK was a recipient
of Carnegie Corporation of New York (USA) fellowship, and
he is currently supported by Wellcome Trust, United Kingdom
(102429/Z/13/Z).
REFERENCES
Arnold, I. C., Dehzad, N., Reuter, S., Martin, H., Becher, B., Taube, C., et al.
(2011). Helicobacter pylori infection prevents allergic asthma in mouse models
through the induction of regulatory T cells. Clin. Invest J. 121, 3088–3093. doi:
10.1172/JCI45041
Arrieta, M., Stiemsma, L. T., Dimitriu, P. A., Thorson, L., Russell, S.,
Yurist-doutsch, S., et al. (2015). Early infancy microbial and metabolic
alterations affect risk of childhood asthma. Sci. Transl. Med. 7, 1–14. doi:
10.1126/scitranslmed.aab2271
Arshi, S., Fallahpour, M., Nabavi, M., Bemanian, M. H., Javad-Mousavi, S.
A., Nojomi, M., et al. (2014). The effects of vitamin D supplementation
on airway functions in mild to moderate persistent asthma. Ann.
Allergy Asthma Immunol. 113, 404–409. doi: 10.1016/j.anai.2014.
07.005
Arslanoglu, S., Moro, G. E., Boehm, G., Wienz, F., Stahl, B., and Bertino, E. (2012).
Early Neutral Prebiotic Oligosaccharide Supplentation reduces the incidence of
some allergic manifestations in the first 5 years of life. J. Biol. Regul. Homeost.
Agents 26, 49–59.
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose,
Y., et al. (2011). Induction of colonic regulatory T cells by indigenous
Clostridium species. Science 331, 337–341. doi: 10.1126/science.
1198469
Azad, M. B., and Kozyrskyj, A. L. (2012). Perinatal programming of
asthma: the role of gut microbiota. Clin. Dev. Immunol. 2012:932072. doi:
10.1155/2012/932072
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M.,
FitzGerald, M., et al. (2008). Global strategy for asthma management and
prevention: GINA executive summary. Eur. Respir. J. 31, 143–178. doi:
10.1183/09031936.00138707
Frontiers in Microbiology | www.frontiersin.org 6 June 2016 | Volume 7 | Article 838
Claassen-Weitz et al. Fecal Bacteria and Asthma
Bisgaard, H., Li, N., Bonnelykke, K., Chawes, B. L. K., Skov, T., Paludan-Müller,
G., et al. (2011). Reduced diversity of the intestinal microbiota during infancy
is associated with increased risk of allergic disease at school age. J. Allergy Clin.
Immunol. 128, 646–652. doi: 10.1016/j.jaci.2011.04.060
Blaser, M. J., and Falkow, S. (2009). What are the consequences of the disappearing
human microbiota? Nat. Rev. Microbiol. 7, 887–894. doi: 10.1038/nrmicro2245
Bloomfield, S., Stanwell-Smith, R., Crevelz, R., and Pickup, J. (2006). Too clean, or
not too clean: the Hygiene Hypothesis and home hygiene. Clin. Exp. Allergy 36,
402–425. doi: 10.1111/j.1365-2222.2006.02463.x
Brehm, J. M., Celedón, J. C., Soto-Quiros, M. E., Avila, L., Hunninghake, G.
M., and Forno, E. (2009). Serum vitamin D levels and markers of severity of
childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 179, 765–771.
doi: 10.1164/rccm.200808-1361OC
Brehm, J. M., Schuemann, B., Fuhlbrigge, A. L., Hollis, B. W., Strunk, R. C., Zeiger,
R. S., et al. (2010). Serum vitamin D levels and severe asthma exacerbations in
the childhood Asthma management program study. J. Allergy Clin. Immunol.
126, 52–58. doi: 10.1016/j.jaci.2010.03.043
Brooks, C., Pearce, N., and Douwes, J. (2013). The hygiene hypothesis in allergy
and asthma: an update. Curr. Opin. Allergy Clin. Immunol. 13, 70–77. doi:
10.1097/ACI.0b013e32835ad0d2
Caselli, M., Vaira, G., Calo, G., Papini, F., Holton, J., and Vaira, D. (2011).
Structural bacterial molecules as potential candidates for an evolution
of the classical concept of probiotics. Adv. Nutr. 2, 372–376. doi:
10.3945/an.111.000604
Castro-Rodriguez, J. A. (2010). The Asthma Predictive Index: a very useful tool for
predicting asthma in young children. J. Allergy Clin. Immunol. 126, 212–216.
doi: 10.1016/j.jaci.2010.06.032
Clemente, J. C., Ursell, L. K., Parfrey, L. W., and Knight, R. (2012). The impact of
the gut microbiota on human health: an integrative view. Cell 148, 1258–1270.
doi: 10.1016/j.cell.2012.01.035
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S.,
et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative
study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A.
107, 14691–14696. doi: 10.1073/pnas.1005963107
De Kivit, S., Tobin, M. C., Forsyth, C. B., Keshavarzian, A., and Landay,
A. L. (2014). Regulation of intestinal immune responses through TLR
activation: Implications for pro- and prebiotics. Front. Immunol. 5:60. doi:
10.3389/fimmu.2014.00060
Dogaru, C. M., Nyffenegger, D., Pescatore, A. M., Spycher, B. D., and Kuehni,
C. E. (2014). Breastfeeding and childhood asthma: Systematic review and
meta-analysis. Am. J. Epidemiol. 179, 1153–1167. doi: 10.1093/aje/kwu072
Edwards, M. R., Bartlett, N. W., Hussell, T., Openshaw, P., and Johnston, S. L.
(2012). The microbiology of asthma. Nat. Rev. Microbiol. 10, 459–471. doi:
10.1038/nrmicro2801
Elazab, N., Mendy, A., Gasana, J., Vieira, E. R., Quizon, A., and Forno, E. (2013).
Probiotic administration in early life, atopy, and asthma: a meta-analysis of
clinical trials. Pediatrics 132, e666–e676. doi: 10.1542/peds.2013-0246
Eloe-fadrosh, E. A., Brady, A., Crabtree, J., Drabek, E. F., Ma, B., Mahurkar, A., et al.
(2015). Functional dynamics of the gut microbiome in elderly people during
probiotic consumption.MBio 6, 1–12. doi: 10.1128/mBio.00231-15
Feleszko, W., Jaworska, J., Rha, R. D., Steinhausen, S., Avagyan, A., Jaudszus,
A., et al. (2007). Probiotic-induced suppression of allergic sensitization and
airway inflammation is associated with an increase of T regulatory-dependent
mechanisms in a murine model of asthma. Clin. Exp. Allergy 37, 498–505. doi:
10.1111/j.1365-2222.2006.02629.x
Fijan, S. (2014). Microorganisms with claimed probiotic properties: an overview
of recent literature. Int. J. Environ. Res. Public Health 11, 4745–4767. doi:
10.3390/ijerph110504745
Forsythe, P. (2011). Probiotics and lung diseases. Chest 139, 901–908. doi:
10.1378/chest.10-1861
Fraher, M. H., O’Toole, P. W., and Quigley, E. M. (2012). Techniques
used to characterize the gut microbiota: a guide for the clinician.
Nat. Rev. Gastroenterol. Hepatol. 9, 312–322. doi: 10.1038/nrgastro.
2012.44
Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau,
C., et al. (2009). The key role of segmented filamentous bacteria in the
coordinated maturation of gut helper T cell responses. Immunity 31, 677–689.
doi: 10.1016/j.immuni.2009.08.020
Goleva, E., Jackson, L. P., Harris, J. K., Robertson, C. E., Sutherland, E. R.,
Hall, C. F., et al. (2013). The effects of airway microbiome on corticosteroid
responsiveness in asthma. Am. J. Respir. Crit. Care Med. 188, 1193–1201. doi:
10.1164/rccm.201304-0775OC
Gosalbes, M. J., Llop, S., Vallès, Y., Moya, A., Ballester, F., and Francino, M. P.
(2012).Meconiummicrobiota types dominated by lactic acid or enteric bacteria
are differentially associated with maternal eczema and respiratory problems in
infants. Clin. Exp. Allergy 43, 198–211. doi: 10.1111/cea.12063
Grzes´kowiak, Ł., Collado, M. C., Mangani, C., Maleta, K., Laitinen, K., Ashorn,
P., et al. (2012). Distinct gut microbiota in southeastern African and
northern European infants. J. Paediatr. Gastroenterol. Nutr. 54, 812–816. doi:
10.1097/MPG.0b013e318249039c
Hanski, I., von Hertzen, L., Fyhrquist, N., Koskinen, K., Torppa, K., Laatikainen,
T., et al. (2012). Environmental biodiversity, human microbiota, and
allergy are interrelated. Proc. Natl. Acad. Sci. U.S.A. 109, 8334–8339. doi:
10.1073/pnas.1205624109
Herbst, T., Sichelstiel, A., Schär, C., Yadava, K., Bürki, K., Cahenzli, J., et al.
(2011). Dysregulation of allergic airway inflammation in the absence of
microbial colonization. Am. J. Respir. Crit. Care Med. 184, 198–205. doi:
10.1164/rccm.201010-1574OC
Hill, D. A., and Artis, D. (2010). Intestinal bacteria and the regulation of immune
cell homeostasis. Annu. Rev. Immunol. 28, 623–667. doi: 10.1146/annurev-
immunol-030409-101330
Hunter, P. (2012). The changing hypothesis of the gut. The intestinal microbiome
is increasingly seen as vital to human health. EMBO Rep. 13, 498–500. doi:
10.1038/embor.2012.68
Ivanov, I. I., Frutos Rde, L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B.,
et al. (2008). Specific microbiota direct the differentiation of IL-17-producing
T-helper cells in themucosa of the small intestine.Cell HostMicrobe 4, 337–349.
doi: 10.1016/j.chom.2008.09.009
Jeurink, P. V., Van Esch, B. C., Rijnierse, A., Garssen, J., and Knippels, L. M.
(2013). Mechanisms underlying immune effects of dietary oligosaccharides.
Am. J. Clin. Nutr. 98, 572S–577S. doi: 10.3945/ajcn.112.038596
Jin, D., Wu, S., Zhang, Y. G., Lu, R., Xia, Y., Dong, H., et al. (2015). Lack of Vitamin
D receptor causes dysbiosis and changes the functions of the murine intestinal
microbiome. Clin. Ther. 37, 996–1009. doi: 10.1016/j.clinthera.2015.04.004
Karimi, K., Inman, M. D., Bienenstock, J., and Forsythe, P. (2009). Lactobacillus
reuteri–induced regulatory T cells protect against an allergic airway response in
mice. Am. J. Respir. Crit. Care Med. 179, 186–193. doi: 10.1164/rccm.200806-
951OC
Kim, H. J., Kim, Y. J., Lee, S. -H., Kang, M. J., Yu, H. -S., Jung, Y. H., et al. (2013).
Effects of Lactobacillus rhamnosus on asthma with an adoptive transfer of
dendritic cells in mice. J. Appl. Microbiol. 115, 872–879. doi: 10.1111/jam.12268
Kim, Y. G., Udayanga, K. G., Totsuka, N., Weinberg, J. B., Núñez, G., and Shibuya,
A. (2014). Gut dysbiosis promotes M2 macrophage polarization and allergic
airway inflammation via fungi-induced PGE2. Cell Host Microbe 15, 95–102.
doi: 10.1016/j.chom.2013.12.010
Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., et al.
(2012). MR1 presents microbial vitamin B metabolites to MAIT cells. Nature
491, 717–723. doi: 10.1038/nature11605
Knights, D., Ward, T. L., Mckinlay, C. E., Miller, H., Gonzalez, A., and Mcdonald,
D. (2014). Rethinking “Enterotypes.” Cell Host Microbe 16, 433–437. doi:
10.1016/j.chom.2014.09.013
Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F.,
et al. (2012). Bifidobacterium infantis 35624 administration induces Foxp3 T
regulatory cells in human peripheral blood: potential role for myeloid and
plasmacytoid dendritic cells.Gut 61, 354–366. doi: 10.1136/gutjnl-2011-300936
Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., et al.
(2013). A guide to enterotypes across the human body: meta-analysis of
microbial community structures in humanmicrobiome datasets. PLoS Comput.
Biol. 9:e1002863. doi: 10.1371/journal.pcbi.1002863
Kozyrskyj, A. L., Bahreinian, S., and Azad, M. B. (2011). Early life exposures:
impact on asthma and allergic disease. Curr. Opin. Allergy Clin. Immunol. 11,
400–406. doi: 10.1097/ACI.0b013e328349b166
Kramer, A., Bekeschus, S., Bröker, B. M., Schleibinger, H., Razavi, B., and Assadian,
O. (2013). Maintaining health by balancing microbial exposure and prevention
of infection: the hygiene hypothesis versus the hypothesis of early immune
challenge. J. Hosp. Infect. 83, S29–S34. doi: 10.1016/S0195-6701(13)60007-9
Frontiers in Microbiology | www.frontiersin.org 7 June 2016 | Volume 7 | Article 838
Claassen-Weitz et al. Fecal Bacteria and Asthma
Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., et al.
(2007). Comparative metagenomics revealed commonly enriched gene sets in
human gut microbiomes. DNA Res. 14, 169–181. doi: 10.1093/dnares/dsm018
Kuzela, L., Vavrecka, A., Prikazska, M., Drugda, B., Hronec, J., Senkova, A., et al.
(1999). Pulmonary complications in patients with inflammatory bowel disease.
Hepatogastroenterology 46, 1714–1719.
Le Bourhis, L., Guerri, L., Dusseaux, M., Martin, E., Soudais, C., and Lantz, O.
(2011). Mucosal-associated invariant T cells: unconventional development and
function. Trends Immunol. 32, 212–218. doi: 10.1016/j.it.2011.02.005
Le Bourhis, L., Mburu, Y. K., and Lantz, O. (2013). MAIT cells, surveyors of a new
class of antigen: development and functions.Curr. Opin. Immunol. 25, 174–180.
doi: 10.1016/j.coi.2013.01.005
Lin, A., Bik, E. M., Costello, E. K., Dethlefsen, L., Haque, R., Relman, D. A., et al.
(2013). Distinct distal gut microbiome diversity and composition in healthy
children from Bangladesh and the United States. PLoS ONE 8:e53838. doi:
10.1371/journal.pone.0053838
MacSharry, J., O’Mahony, C., Shalaby, K. H., Sheil, B., Karmouty-Quintana,
H., Shanahan, F., et al. (2012). Immunomodulatory effects of feeding with
Bifidobacterium longum on allergen-induced lung inflammation in the mouse.
Pulm. Pharmacol. Ther. 25, 325–334. doi: 10.1016/j.pupt.2012.05.011
Mai, V., McCrary, Q. M., Sinha, R., and Glei, M. (2009). Associations between
dietary habits and body mass index with gut microbiota composition and fecal
water genotoxicity: an observational study in African American and Caucasian
American volunteers. Nutr. J. 8:49. doi: 10.1186/1475-2891-8-49
Mallol, J. (2008). Asthma in Latin America: where the asthma causative/protective
hypotheses fail. Allergol. Immunopathol. (Madr). 36, 150–153. doi:
10.1016/S0301-0546(08)72540-0
Mann, E. H., Chambers, E. S., Pfeffer, P. E., and Hawrylowicz, C. M. (2014).
Immunoregulatorymechanisms of vitamin D relevant to respiratory health and
asthma. Ann. N.Y. Acad. Sci. 1317, 57–69. doi: 10.1111/nyas.12410
Mansson, I., and Colldahl, H. (1965). The intestinal flora in patients with bronchial
asthma and rheumatoid arthritis. Allergy 20, 94–104. doi: 10.1111/j.1398-
9995.1965.tb03360.x
Marra, F., Marra, C. A., Richardson, K., Lynd, L. D., Kozyrskyj, A., Patrick,
D. M., et al. (2009). Antibiotic use in children is associated with
increased risk of asthma. Pediatrics 123, 1003–1010. doi: 10.1542/peds.
2008-1146
Masoli, M., Fabian, D., Holt, S., and Beasley, R. (2004). The global burden of
asthma: executive summary of the GINA Dissemination Committee report.
Allergy 59, 469–478. doi: 10.1111/j.1398-9995.2004.00526.x
McLoughlin, R. M., and Mills, K. H. (2011). Influence of gastrointestinal
commensal bacteria on the immune responses that mediate allergy and asthma.
J. Allergy Clin. Immunol. 127, 1097. doi: 10.1016/j.jaci.2011.02.012
Mohamed-Hussein, A. A., Mohamed, N. A., and Ibrahim, M. E. (2007). Changes
in pulmonary function in patients with ulcerative colitis. Respir. Med. 101,
977–982. doi: 10.1016/j.rmed.2006.09.005
Morgan, X. C., and Huttenhower, C. (2014). Meta’omic analytic techniques for
studying the intestinal microbiome. Gastroenterology 146, 1437–1448. doi:
10.1053/j.gastro.2014.01.049
Murk, W., Risnes, K. R., and Bracken, M. B. (2011). Prenatal or early-life exposure
to antibiotics and risk of childhood asthma: a systematic review. Pediatrics 127,
1125–1138. doi: 10.1542/peds.2010-2092
Nambu, M., Shintaku, N., and Ohta, S. (2008). Intestinal microflora at 4 months
of age and the development of allergy. Allergol. Int. 53, 121–126. doi:
10.1111/j.1440-1592.2004.00315.x
Navarro, S., Cossalter, G., Chiavaroli, C., Kanda, A., Fleury, S., Lazzari, A., et al.
(2011). The oral administration of bacterial extracts prevents asthma via the
recruitment of regulatory T cells to the airways. Mucosal Immunol. 4, 53–65.
doi: 10.1038/mi.2010.51
Oertli, M., Sundquist, M., Hitzler, I., Engler, D. B., Arnold, I. C., Reuter, S.,
et al. (2012). DC-derived IL-18 drives Treg differentiation, murine Helicobacter
pylori-specific immune tolerance, and asthma protection. J. Clin. Invest. 122,
1082–1096. doi: 10.1172/JCI61029
Osborn, D., and Sinn, J. (2013). Prebiotics in infants for prevention of allergy.
Cochrane Database Syst. Rev. 3:CD006474. doi: 10.1002/14651858.CD006474.
pub3
Ou, J., Carbonero, F., Zoetendal, E. G., Delany, J. P., Wang, M., Newton, K., et al.
(2013). Diet, microbiota, and microbial metabolites in colon cancer risk in
rural Africans and African Americans. Am. J. Clin. Nutr. 98, 111–120. doi:
10.3945/ajcn.112.056689
Palm, N. W., De Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J.,
Hao, L., et al. (2014). Immunoglobulin A coating identifies colitogenic
bacteria in inflammatory bowel disease. Cell 158, 1000–1010. doi:
10.1016/j.cell.2014.08.006
Patel, O., Kjer-Nielsen, L., Le Nours, J., Eckle, S. B. G., Birkinshaw, R., Beddoe,
T., et al. (2013). Recognition of vitamin B metabolites by mucosal-associated
invariant T cells. Nat. Commun. 4, 2142. doi: 10.1038/ncomms3142
Pedersen, S. (2007). Preschool asthma - not so easy to diagnose. Prim. Care Respir.
16, 4–6. doi: 10.3132/pcrj.2007.00011
Pedersen, S. E., Hurd, S. S., Lemanske, R. F., Becker, A., Zar, H. J., Sly, P. D.,
et al. (2011). Global strategy for the diagnosis and management of asthma in
children 5 years and younger. Pediatr. Pulmonol. 46, 1–17. doi: 10.1002/ppul.
21321
Penders, J., Kummeling, I., and Thijs, C. (2011). Infant antibiotic use and wheeze
and asthma risk: a systematic review and meta-analysis. Eur. Respir. J. 38,
295–302. doi: 10.1183/09031936.00105010
Penders, J., Stobberingh, E. E., Van den Brandt, P. A., and Thijs, C. (2007). The role
of the intestinal microbiota in the development of atopic disorders. Allergy 62,
1223–1236. doi: 10.1111/j.1398-9995.2007.01462.x
Peng, Y. H., Liao, W. C., Su, C. H., Chen, H. J., Hsia, T. C., Chu, C. C., et al. (2015).
Association of inflammatory bowel disease with asthma risk: a nationwide
cohort study. Allergy Asthma Proc. 36, e92–e98. doi: 10.2500/aap.2015.36.3869
Qin, J., Li, Y., Cai, Z., Li, S. S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide
association study of gut microbiota in type 2 diabetes. Nature 490, 55–60. doi:
10.1038/nature11450
Quince, C., Ijaz, U. Z., Loman, N., Eren, A. M., Saulnier, D., Russell, J., et al.
(2015). Extensive modulation of the fecal metagenome in children with Crohn’s
Disease during exclusive enteral nutrition. Am. J. Gastroenterol. 1–12. doi:
10.1038/ajg.2015.357
Rajilic´-Stojanovic´, M., Smidt, H., and De Vos, W. M. (2007). Diversity of
the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 9,
2125–2136. doi: 10.1111/j.1462-2920.2007.01369.x
Ranjan, R., Rani, A., Metwally, A., McGee, H. S., and Perkens, D. L. (2015).
Analysis of the microbiome: advantages of whole genome shotgun versus 16S
amplicon sequencing. Biochem. Biophys. Res. Commun. 469, 967–977. doi:
10.1016/j.bbrc.2015.12.083
Risnes, K. R., Belanger, K., Murk, W., and Bracken, M. B. (2010). Antibiotic
exposure by 6 months and asthma and allergy at 6 years: Findings in a cohort
of 1,401 US children. Am. J. Epidemiol. 173, 310–318. doi: 10.1093/aje/kwq400
Rook, G. (2012). Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy
Immunol. 42, 5–15. doi: 10.1007/s12016-011-8285-8
Round, J. L., Lee, S. M., Li, J., Tran, G., Jabri, B., Chatila, T. A., et al. (2011). The
Toll-like receptor 2 pathway establishes colonization by a commensal of the
human microbiota. Science 332, 974. doi: 10.1126/science.1206095
Russell, S. L., and Finlay, B. B. (2012). The impact of gut microbes
in allergic diseases. Curr. Opin. Gastroenterol. 28, 563–569. doi:
10.1097/MOG.0b013e3283573017
Russell, S. L., Gold, M. J., Hartmann, M., Willing, B. P., Thorson, L.,
Wlodarska, M., et al. (2012). Early life antibiotic-driven changes in microbiota
enhance susceptibility to allergic asthma. EMBO Rep. 13, 440–447. doi:
10.1038/embor.2012.32
Russell, S. L., Gold, M. J., Willing, B. P., Thorson, L., McNagny, K. M., and
Finlay, B. B. (2013). Perinatal antibiotic treatment affects murine microbiota,
immune responses and allergic asthma. Gut Microbes 4, 158–164. doi:
10.4161/gmic.23567
Salminen, S., Gibson, G. R., McCartney, A. L., and Isolauri, E. (2004). Influence
of mode of delivery on gut microbiota composition in seven year old children.
Gut 53, 1388–1389. doi: 10.1136/gut.2004.041640
Salzman, N. H. (2011). Microbiota-immune system interaction: an uneasy alliance.
Curr. Opin. Microbiol. 14, 99–105. doi: 10.1016/j.mib.2010.09.018
Samuelson, D. R., Welsch, D. A., and Shellito, J. E. (2015). Regulation of lung
immunity and host defense by the intestinal microbiota. Front. Microbiol.
6:1085. doi: 10.3389/fmicb.2015.01085
Sankar, S. A., Lagier, J. C., Pontarotti, P., Raoult, D., and Fournier, P. E. (2015).
The human gut microbiome, a taxonomic conundrum. Syst. Appl. Microbiol.
38, 276–286. doi: 10.1016/j.syapm.2015.03.004
Frontiers in Microbiology | www.frontiersin.org 8 June 2016 | Volume 7 | Article 838
Claassen-Weitz et al. Fecal Bacteria and Asthma
Schippa, S., and Conte, M. (2014). Dysbiotic events in gut microbiota: Impact on
human health. Nutrients 6, 5786–5805. doi: 10.3390/nu6125786
Sekirov, I., Russell, S. L., Antunes, L. C. M., and Finlay, B. B. (2010).
Gut microbiota in health and disease. Physiol. Rev. 90, 859–904. doi:
10.1152/physrev.00045.2009
Shenderov, B. A. (2013). Metabiotics: novel idea or natural development
of probiotic conception. Microb. Ecol. Health Dis. 24, 1–8. doi:
10.3402/mehd.v24i0.20399
Sim, K., Cox, M. J., Wopereis, H., Martin, R., Knol, J., Li, M. S., et al. (2012).
Improved detection of bifidobacteria with optimised 16S rRNA-gene based
pyrosequencing. PLoS ONE 7:e32543. doi: 10.1371/journal.pone.0032543
Sly, P. D., Boner, A. L., Björksten, B., Bush, A., Custovic, A., Eigenmann, P. A.,
et al. (2008). Early identification of atopy in the prediction of persistent asthma
in children. Lancet 372, 1100–1106. doi: 10.1016/S0140-6736(08)61451-8
Stockert, K. (2001). Physiologische Darmflora bei 6- bis 12-jaehrigen kindern mit
asthma bronchiale.Dt. Ztschr. F. Akup. 44, 268–271. doi: 10.1055/s-2001-19471
Strachan, D. P. (1989). Hay fever, hygiene, and household size. BMJ 299,
1259–1260. doi: 10.1136/bmj.299.6710.1259
Strachan, D. P. (2000). Family size, infection and atopy: the first decade of the
‘hygiene hypothesis’. Thorax 55:S2. doi: 10.1136/thorax.55.suppl_1.S2
Štšepetova, J., Sepp, E., Julge, K., Vaughan, E., Mikelsaar, M., and De Vos, W.
M. (2007). Molecularly assessed shifts of Bifidobacterium ssp. and less diverse
microbial communities are characteristic of 5-year-old allergic children. FEMS
Immunol. Med. Microbiol 51, 260–269. doi: 10.1111/j.1574-695X.2007.00306.x
Suau, A., Bonnet, R., Sutren, M., Godon, J. J., Gibson, G. R., Collins, M. D.,
et al. (1999). Direct analysis of genes encoding 16S rRNA from complex
communities reveals many novel molecular species within the human gut.Appl.
Environ. Microbiol. 65, 4799–4807.
Suzuki, T. A., and Worobey, M. (2014). Geographical variation of human
gut microbial composition Geographical variation of human gut microbial
composition. Biol. Lett. 10, 20131037. doi: 10.1098/rsbl.2013.1037
Taube, C., and Müller, A. (2012). The role of Helicobacter pylori infection in
the development of allergic asthma. Expert Rev. Respir. Med. 6, 441–449. doi:
10.1586/ers.12.40
Taylor, A. L., Dunstan, J. A., and Prescott, S. L. (2007). Probiotic supplementation
for the first 6 months of life fails to reduce the risk of atopic dermatitis
and increases the risk of allergen sensitization in high-risk children: a
randomized controlled trial. J. Allergy Clin. Immunol. 119, 184–191. doi:
10.1016/j.jaci.2006.08.036
Thavagnanam, S., Fleming, J., Bromley, A., Shields, M. D., and Cardwell, C.
R. (2008). A meta-analysis of the association between Caesarean section
and childhood asthma. Clin. Exp. Allergy 38, 629–633. doi: 10.1111/j.1365-
2222.2007.02780.x
Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., et al.
(2003). Selection of evolutionarily conserved mucosal-associated invariant T
cells by MR1. Nature 422, 164–169. doi: 10.1038/nature01433
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N.,
Ngom-Bru, C., et al. (2014). Gut microbiota metabolism of dietary fiber
influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159–166.
doi: 10.1038/nm.3444
Tulic, M. K., Piche, T., and Verhasselt, V. (2016). Lung-gut crosstalk: evidence,
mechanisms and implications for themucosal inflammatory diseases.Clin. Exp.
Allergy 46, 519–528. doi: 10.1111/cea.12723
Vael, C., Nelen, V., Verhulst, S. L., Goossens, H., and Desager, K. N. (2008). Early
intestinal Bacteroides fragilis colonisation and development of asthma. BMC
Pulm. Med. 8:19. doi: 10.1186/1471-2466-8-19
Vael, C., Vanheirstraeten, L., Desager, K. N., and Goossens, H. (2011). Denaturing
gradient gel electrophoresis of neonatal intestinal microbiota in relation to the
development of asthma. BMCMicrobiol. 11:68. doi: 10.1186/1471-2180-11-68
Van de Pol, M. A., Lutter, R., Smids, B. S., Weersink, E. J. M., and Van der
Zee, J. S. (2011). Synbiotics reduce allergen-induced T-helper 2 response and
improve peak expiratory flow in allergic asthmatics. Allergy 66, 39–47. doi:
10.1111/j.1398-9995.2010.02454.x
Van der Aa, L. B., Van Aalderen, W. M. C., Heymans, H. S. A., Henk Sillevis
Smitt, J., Nauta, A. J., Knippels, L. M. J., et al. (2011). Synbiotics prevent
asthma-like symptoms in infants with atopic dermatitis. Allergy 66, 170–177.
doi: 10.1111/j.1398-9995.2010.02416.x
Van der Waaij, L. A., Kroese, F. G., Visser, A., Nelis, G. F., Westerveld, B. D.,
Jansen, P. L., et al. (2004). Immunoglobulin coating of faecal bacteria in
inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 16, 669–674. doi:
10.1097/01.meg.0000108346.41221.19
Van Dijk, E. L., Auger, H., Jaszczyszyn, Y., and Thermes, C. (2014). Ten years
of next-generation sequencing technology. Trends Genet. 30, 418–426. doi:
10.1016/j.tig.2014.07.001
Van Nimwegen, F. A., Penders, J., Stobberingh, E. E., Postma, D. S., Koppelman,
G. H., Kerkhof, M., et al. (2011). Mode and place of delivery, gastrointestinal
microbiota, and their influence on asthma and atopy. J. Allergy Clin. Immunol.
128, 948–955. doi: 10.1016/j.jaci.2011.07.027
Viljanen, M., Pohjavuori, E., Haahtela, T., Korpela, R., Kuitunen, M., Sarnesto, A.,
et al. (2005). Induction of inflammation as a possible mechanism of probiotic
effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 115,
1254–1259. doi: 10.1016/j.jaci.2005.03.047
Vital, M., Harkema, J. R., Rizzo, M., Tiedje, J., and Brandenberger, C. (2015).
Alterations of the murine gut microbiome with age and allergic airway disease.
J. Immunol. Res. 2015, 1–8. doi: 10.1155/2015/892568
Vliagoftis, H., Kouranos, V. D., Betsi, G. I., and Falagas, M. E. (2008). Probiotics
for the treatment of allergic rhinitis and asthma: systematic review of
randomized controlled trials.Ann. Allergy Asthma Immunol. 101, 570–579. doi:
10.1016/S1081-1206(10)60219-0
Vos, A. P., Van Esch, B. C., Stahl, B., M’Rabet, L., Folkerts, G., Nijkamp, F. P.,
et al. (2007). Dietary supplementation with specific oligosaccharide mixtures
decreases parameters of allergic asthma in mice. Int. Immunopharmacol. 7,
1582–1587. doi: 10.1016/j.intimp.2007.07.024
Walker, A.W.,Martin, J. C., Scott, P., Parkhill, J., Flint, H. J., and Scott, K. P. (2015).
16S rRNA gene-based profiling of the human infant gut microbiota is strongly
influenced by sample processing and PCR primer choice.Microbiome 3:26. doi:
10.1186/s40168-015-0087-4
West, C. E. (2014). Gut microbiota and allergic disease: new findings. Curr.
Opin. Clin. Nutr. Metab. Care 17, 261–266. doi: 10.1097/MCO.00000000000
00044
Wold, A. E. (1998). The hygiene hypothesis revised: is the rising frequency
of allergy due to changes in the intestinal flora? Allergy 53, 20–25 doi:
10.1111/j.1398-9995.1998.tb04953.x
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G.,
Contreras, M., et al. (2012). Human gut microbiome viewed across age and
geography. Nature 486, 222–227. doi: 10.1038/nature11053
Zaiss, M. M., Rapin, A., Lebon, L., Dubey, L. K., Mosconi, I., Sarter,
K., et al. (2015). The intestinal microbiota contributes to the ability of
helminths to modulate allergic inflammation. Immunity 43, 998–1010. doi:
10.1016/j.immuni.2015.09.012
Zar, H. J., and Levin, M. E. (2012). Challenges in treating pediatric asthma
in developing countries. Pediatr. Drugs 14, 353–359. doi: 10.2165/11597420-
000000000-00000
Zhang, Q., Cox, M., Liang, Z., Brinkmann, F., Cardenas, P. A., and Duff, R. (2016).
Airway microbiota in severe asthma and relationship to asthma severity and
phenotypes. PLoS ONE 11:e0152724. doi: 10.1371/journal.pone.0152724
Zhao, L. (2013). The gut microbiota and obesity: from correlation
to causality. Nat. Rev. Microbiol. 11, 639–647. doi: 10.1038/
nrmicro3089
Zoetendal, E. G., Vaughan, E. E., and De Vos, W. M. (2006). A microbial
world within us. Mol. Microbiol. 59, 1639–1650. doi: 10.1111/j.1365-
2958.2006.05056.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Claassen-Weitz, Wiysonge, Machingaidze, Thabane, Horsnell,
Zar, Nicol and Kaba. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 9 June 2016 | Volume 7 | Article 838
